Ruth Holm

Publications published since 1983 or in press by Ruth Holm

184 publications found

Publications in press

1. Sigstad E, Paus E, Bjøro T, Berner A, Grøholt KK, Jørgensen LH, Sobrinho-Simões M, Holm R, Warren DJ
   The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors
   Mod Pathol (in press)
   PubMed 22157935

Publications 2012

1. Schee K, Flatmark K, Holm R, Boye K, Paus E (2012)
   Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
   Tumour Biol, 33 (1), 73-83
   PubMed 22006279

Publications 2011

1. Engesæter BO, Sathermugathevan M, Hellenes T, Engebråten O, Holm R, Flørenes VA, Mælandsmo GM (2011)
   Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells
   Cancer Biol Ther, 12 (1), 47-58
   PubMed 21508672
2. Halle C, Lando M, Sundfør K, Kristensen GB, Holm R, Lyng H (2011)
   Phosphorylation of EGFR measured with in situ proximity ligation assay: relationship to EGFR protein level and gene dosage in cervical cancer
   Radiother Oncol, 101 (1), 152-7
   PubMed 21680035
3. Halle C, Lando M, Svendsrud DH, Clancy T, Holden M, Sundfør K, Kristensen GB, Holm R, Lyng H (2011)
   Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer
   Clin Cancer Res, 17 (16), 5501-12
   PubMed 21737508
4. Helland Å, Anglesio MS, George J, Cowin PA, Johnstone CN, House CM, Sheppard KE, Etemadmoghadam D, Melnyk N, Rustgi AK, Phillips WA, Johnsen H, Holm R, Kristensen GB, Birrer MJ, Australian Ovarian Cancer Study Group, Pearson RB, Børresen-Dale AL, Huntsman DG, deFazio A, Creighton CJ, Smyth GK, Bowtell DD (2011)
   Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers
   PLoS One, 6 (4), e18064
   PubMed 21533284
5. Wang Z, Nesland JM, Suo Z, Trope CG, Holm R (2011)
   The prognostic value of 14-3-3 isoforms in vulvar squamous cell carcinoma cases: 14-3-3? and ? are independent prognostic factors for these tumors
   PLoS One, 6 (9), e24843
   PubMed 21935479

Publications 2010

1. Callen DF, Ricciardelli C, Butler M, Stapleton A, Stahl J, Kench JG, Horsfall DJ, Tilley WD, Schulz R, Nesland JM, Neilsen PM, Kumar R, Holm R (2010)
   Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome
   Oncol Rep, 23 (4), 1045-52
   PubMed 20204290
2. Evang JA, Borota OC, Melum E, Holm R, Ramm-Pettersen J, Bollerslev J, Berg JP (2010)
   HDAC2 expression and variable number of repeats in exon 1 of the HDAC2 gene in corticotroph adenomas
   Clin Endocrinol (Oxf), 73 (2), 229-35
   PubMed 20346000
3. Fedorcsák P, Polec A, Ráki M, Holm R, Jebsen P, Abyholm T (2010)
   Differential release of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human granulosa-lutein cells and ovarian leukocytes
   Endocrinology, 151 (3), 1290-8
   PubMed 20051489
4. Khouja MH, Baekelandt M, Sarab A, Nesland JM, Holm R (2010)
   Limitations of tissue microarrays compared with whole tissue sections in survival analysis
   Oncol. Lett., 1 (5), 827-831
5. Wang Z, He W, Yang G, Wang J, Wang Z, Nesland JM, Holm R, Suo Z (2010)
   Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma
   BMC Cancer, 10, 352
   PubMed 20602752
6. Wang Z, Trope CG, Flørenes VA, Suo Z, Nesland JM, Holm R (2010)
   Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
   BMC Cancer, 10, 233
   PubMed 20500813

Publications 2009

1. Holm R, Ali T, Svendsrud DH, Nesland JM, Kristensen GB, Lyng H (2009)
   Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome
   Oncol Rep, 22 (1), 11-5
   PubMed 19513498
2. Knopp S, Tropè C, Nesland JM, Holm R (2009)
   A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice
   J Clin Pathol, 62 (3), 212-8
   PubMed 19251952

Publications 2008

1. Holm R, de Putte GV, Suo Z, Lie AK, Kristensen GB (2008)
   Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis
   Int J Med Sci, 5 (3), 121-6
   PubMed 18566674
2. Holm R, Knopp S, Kumar R, Lee J, Nesland JM, Tropè C, Callen DF (2008)
   Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis
   J Clin Pathol, 61 (1), 59-63
   PubMed 17468294
3. Holm R, Kraus I, Skomedal H, Langerød A, Kristensen GB, Lyng H (2008)
   Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma
   Open Virol J, 2, 74-81
   PubMed 19440467
4. Wang Z, Tropè CG, Suo Z, Trøen G, Yang G, Nesland JM, Holm R (2008)
   The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas
   BMC Cancer, 8, 308
   PubMed 18950492

Publications 2007

1. Holm R, Knopp S, Suo Z, Tropè C, Nesland JM (2007)
   Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis
   J Clin Pathol, 60 (10), 1086-91
   PubMed 17158642
2. Khouja MH, Baekelandt M, Nesland JM, Holm R (2007)
   The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma
   Int J Gynecol Pathol, 26 (4), 418-25
   PubMed 17885492

Publications 2006

1. Knopp S, Holm R, Bjørge T, Tropé C, Nesland JM (2006)
   Cell cycle regulation in primary vulvar carcinomas and related lymph node metastases
   Histopathology, 49 (3), 311-2
   PubMed 16918980
2. Knopp S, Nesland JM, Tropé C, Holm R (2006)
   p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma
   Am J Clin Pathol, 126 (2), 266-76
   PubMed 16891203
3. Kraus I, Molden T, Holm R, Lie AK, Karlsen F, Kristensen GB, Skomedal H (2006)
   Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas
   J Clin Microbiol, 44 (4), 1310-7
   PubMed 16597856
4. Lyng H, Brøvig RS, Svendsrud DH, Holm R, Kaalhus O, Knutstad K, Oksefjell H, Sundfør K, Kristensen GB, Stokke T (2006)
   Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
   BMC Genomics, 7, 268
   PubMed 17054779
5. Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MMO, Olivier M, Skomedal H, Hainaut P, Trope CG, Abeler VM, Nesland JM, Borresen-Dale AL, Helland A (2006)
   Effect of the codon 72 polymorphism (c.215G > C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma (vol 24, pg 21, 2004)
   Hum. Mutat., 27 (2), 209-210

Publications 2005

1. Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z (2005)
   The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas
   Gynecol Oncol, 99 (2), 278-86
   PubMed 16061279
2. Holm R (2005)
   In situ hybridization methods to study microbial populations and their interactions with human host cells
   Methods Microbiol., 34, 1-+
3. Knopp S, Bjørge T, Nesland JM, Tropé C, Holm R (2005)
   Cyclins D1, D3, E, and A in vulvar carcinoma patients
   Gynecol Oncol, 97 (3), 733-9
   PubMed 15894358
4. Knopp S, Holm R, Tropé C, Nesland JM (2005)
   Occult lymph node metastases in early stage vulvar carcinoma patients
   Gynecol Oncol, 99 (2), 383-7
   PubMed 16051338
5. Slipicevic A, Holm R, Nguyen MT, Bøhler PJ, Davidson B, Flørenes VA (2005)
   Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome
   Am J Clin Pathol, 124 (4), 528-36
   PubMed 16146807
6. Van de Putte G, Holm R, Lie AK, Baekelandt M, Kristensen GB (2005)
   Markers of apoptosis in stage IB squamous cervical carcinoma
   J Clin Pathol, 58 (6), 590-4
   PubMed 15917408
7. Wang Y, Helland A, Holm R, Kristensen GB, Børresen-Dale AL (2005)
   PIK3CA mutations in advanced ovarian carcinomas
   Hum Mutat, 25 (3), 322
   PubMed 15712344
8. Wang Y, Kristensen GB, Helland A, Nesland JM, Børresen-Dale AL, Holm R (2005)
   Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas
   Am J Clin Pathol, 124 (3), 392-401
   PubMed 16191507

Publications 2004

1. Andersen K, Nesland JM, Holm R, Flørenes VA, Fodstad Ø, Maelandsmo GM (2004)
   Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma
   Mod Pathol, 17 (8), 990-7
   PubMed 15133476
2. Flørenes VA, Maelandsmo GM, Holm R, Reich R, Lazarovici P, Davidson B (2004)
   Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome
   Am J Clin Pathol, 122 (3), 412-20
   PubMed 15362372
3. Knopp S, Bjørge T, Nesland JM, Tropé C, Scheistrøen M, Holm R (2004)
   p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas
   Gynecol Oncol, 95 (1), 37-45
   PubMed 15385108
4. Van de Putte G, Kristensen GB, Baekelandt M, Lie AK, Holm R (2004)
   E-cadherin and catenins in early squamous cervical carcinoma
   Gynecol Oncol, 94 (2), 521-7
   PubMed 15297198
5. Van de Putte G, Kristensen GB, Lie AK, Baekelandt M, Holm R (2004)
   Cyclins and proliferation markers in early squamous cervical carcinoma
   Gynecol Oncol, 92 (1), 40-6
   PubMed 14751136
6. Van de Putte GV, Holm R, Lie AK, Trope CG, Kristensen GB (2004)
   Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis (vol 89, pg 140, 2003)
   Gynecol. Oncol., 92 (2), 730
7. Wang Y, Helland A, Holm R, Skomedal H, Abeler VM, Danielsen HE, Tropé CG, Børresen-Dale AL, Kristensen GB (2004)
   TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival
   Br J Cancer, 90 (3), 678-85
   PubMed 14760384
8. Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Tropé CG, Abeler VM, Nesland JM, Børresen-Dale AL, Helland A (2004)
   Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma
   Hum Mutat, 24 (1), 21-34
   PubMed 15221786
9. Wu D, Qiao Y, Kristensen GB, Li S, Troen G, Holm R, Nesland JM, Suo Z (2004)
   Prognostic significance of dysadherin expression in cervical squamous cell carcinoma
   Pathol Oncol Res, 10 (4), 212-8
   PubMed 15619642
10. Wu D, Suo Z, Kristensen GB, Li S, Troen G, Holm R, Nesland JM (2004)
    Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma
    Gynecol Oncol, 94 (2), 312-9
    PubMed 15297167

Publications 2003

1. Bukholm IR, Bukholm G, Holm R, Nesland JM (2003)
   Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas
   J Clin Pathol, 56 (5), 368-73
   PubMed 12719458
2. Jørgensen K, Holm R, Maelandsmo GM, Flørenes VA (2003)
   Expression of activated extracellular signal-regulated kinases 1/2 in malignant melanomas: relationship with clinical outcome
   Clin Cancer Res, 9 (14), 5325-31
   PubMed 14614017
3. Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA (2003)
   Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma
   Clin Cancer Res, 9 (9), 3383-8
   PubMed 12960126
4. Reed W, Sandstad B, Holm R, Nesland JM (2003)
   The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators
   Int J Surg Pathol, 11 (2), 65-74
   PubMed 12754622
5. Skomedal H, Forus A, Holm R (2003)
   Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer
   Anticancer Res, 23 (5A), 3929-35
   PubMed 14666699
6. Skotheim RI, Abeler VM, Nesland JM, Fosså SD, Holm R, Wagner U, Flørenes VA, Aass N, Kallioniemi OP, Lothe RA (2003)
   Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
   Neoplasia, 5 (5), 397-404
   PubMed 14670177
7. Thorstensen L, Holm R, Lothe RA, Tropé C, Carvalho B, Sobrinho-Simoes M, Seruca R (2003)
   WNT-inducible signaling pathway protein 3, WISP-3, is mutated in microsatellite unstable gastrointestinal carcinomas but not in endometrial carcinomas
   Gastroenterology, 124 (1), 270-1
   PubMed 12512062
8. Van de Putte G, Holm R, Lie AK, Trope CG, Kristensen GB (2003)
   Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis (vol 89, pg 140, 2003)
   Gynecol. Oncol., 90 (1), 231
9. van de Putte G, Holm R, Lie AK, Tropé CG, Kristensen GB (2003)
   Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis
   Gynecol Oncol, 89 (1), 140-7
   PubMed 12694668

Publications 2002

1. Kraggerud SM, Aman P, Holm R, Stenwig AE, Fosså SD, Nesland JM, Lothe RA (2002)
   Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis
   Cancer Res, 62 (2), 512-7
   PubMed 11809703
2. Lopes JM, Nesland JM, Reis-Filho JS, Holm R (2002)
   Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin
   Histopathology, 40 (5), 464-71
   PubMed 12010367
3. Røtterud R, Pettersen EO, Berner A, Holm R, Olsen DR, Fosså SD (2002)
   Cell cycle inhibitors and outcome after radiotherapy in bladder cancer patients
   Acta Oncol, 41 (5), 463-70
   PubMed 12442923

Publications 2001

1. Dai H, Holm R, Kristensen GB, Abeler VM, Børresen-Dale AL, Helland A (2001)
   Fibroblast growth factor receptor 3 (FGFR3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas
   Anal Cell Pathol, 23 (2), 45-9
   PubMed 11904459
2. Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R (2001)
   Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome
   J Pathol, 195 (5), 530-6
   PubMed 11745687
3. Holm R, Skovlund E, Skomedal H, Flørenes VA, Tanum G (2001)
   Reduced expression of p21WAF1 is an indicator of malignant behaviour in anal carcinomas
   Histopathology, 39 (1), 43-9
   PubMed 11454043
4. Røtterud R, Berner A, Holm R, Skovlund E, Fosså SD (2001)
   p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder
   BJU Int, 88 (3), 202-8
   PubMed 11488730

Publications 2000

1. Baekelandt M, Holm R, Nesland JM, Tropé CG, Kristensen GB (2000)
   Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer
   J Clin Oncol, 18 (22), 3775-81
   PubMed 11078490
2. Baekelandt MM, Holm R, Nesland JM, Tropé CG, Kristensen GB (2000)
   P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer
   Anticancer Res, 20 (2B), 1061-7
   PubMed 10810398
3. De Jonge ET, Lindeque BG, Burger W, Nesland JM, Holm R (2000)
   Predicting response to neoadjuvant chemotherapy in patients with cervical carcinoma: can we do without any longer?
   Int J Gynecol Cancer, 10 (2), 137-142
   PubMed 11240665
4. Flørenes VA, Faye RS, Maelandsmo GM, Nesland JM, Holm R (2000)
   Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma
   Clin Cancer Res, 6 (9), 3614-20
   PubMed 10999753
5. Helland A, Kraggerud SM, Kristensen GB, Holm R, Abeler VM, Huebner K, Borresen-Dale AL, Lothe RA (2000)
   Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival
   Int J Cancer, 88 (2), 217-22
   PubMed 11004671
6. Holm R (2000)
   A highly sensitive nonisotopic detection method for in situ hybridization
   Appl Immunohistochem Mol Morphol, 8 (2), 162-5
   PubMed 10937065

Publications 1999

1. Baekelandt M, Holm R, Tropé CG, Nesland JM, Kristensen GB (1999)
   The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer
   Ann Oncol, 10 (11), 1335-41
   PubMed 10631462
2. Baekelandt M, Holm R, Tropé CG, Nesland JM, Kristensen GB (1999)
   Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study
   Clin Cancer Res, 5 (10), 2848-53
   PubMed 10537352
3. Baekelandt M, Kristensen GB, Nesland JM, Tropé CG, Holm R (1999)
   Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer
   J Clin Oncol, 17 (7), 2061
   PubMed 10561259
4. Baekelandt M, Kristensen GB, Tropé CG, Nesland JM, Holm R (1999)
   Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer
   Anticancer Res, 19 (5C), 4469-74
   PubMed 10650794
5. De Jonge ET, Viljoen E, Lindeque BG, Amant F, Nesland JM, Holm R (1999)
   The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy
   Int J Gynecol Cancer, 9 (3), 198-205
   PubMed 11240767
6. Hennig EM, Di Lonardo A, Venuti A, Holm R, Marcante ML, Nesland JM (1999)
   HPV 16 in multiple neoplastic lesions in women with CIN III
   J Exp Clin Cancer Res, 18 (3), 369-77
   PubMed 10606184
7. Hennig EM, Kvinnsland S, Holm R, Nesland JM (1999)
   Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas
   Acta Oncol, 38 (7), 931-8
   PubMed 10606422
8. Hennig EM, Suo Z, Karlsen F, Holm R, Thoresen S, Nesland JM (1999)
   HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III)
   Acta Oncol, 38 (5), 639-47
   PubMed 10427955
9. Hennig EM, Suo Z, Thoresen S, Holm R, Kvinnsland S, Nesland JM (1999)
   Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III)
   Breast Cancer Res Treat, 53 (2), 121-35
   PubMed 10326789
10. Lie AK, Skarsvåg S, Skomedal H, Haugen OA, Holm R (1999)
    Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection
    Int J Gynecol Pathol, 18 (1), 5-11
    PubMed 9891236
11. Reed W, Flørems VA, Holm R, Hannisdal E, Nesland JM (1999)
    Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients
    Virchows Arch, 435 (2), 116-24
    PubMed 10599310
12. Skomedal H, Helland A, Kristensen GB, Holm R, Børresen-Dale AL (1999)
    Allelic imbalance at chromosome region 11q23 in cervical carcinomas
    Eur J Cancer, 35 (4), 659-63
    PubMed 10492643
13. Skomedal H, Kristensen GB, Lie AK, Holm R (1999)
    Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas
    Gynecol Oncol, 73 (2), 223-8
    PubMed 10329038
14. Skomedal H, Kristensen GB, Nesland JM, Børresen-Dale AL, Tropé C, Holm R (1999)
    TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus
    J Pathol, 187 (5), 556-62
    PubMed 10398121

Publications 1998

1. Flørenes VA, Maelandsmo GM, Kerbel RS, Slingerland JM, Nesland JM, Holm R (1998)
   Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival
   Am J Pathol, 153 (1), 305-12
   PubMed 9665492
2. Helland A, Karlsen F, Due EU, Holm R, Kristensen G, Børresen-Dale A (1998)
   Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load
   Br J Cancer, 78 (1), 69-72
   PubMed 9662253
3. Kalantari M, Karlsen F, Kristensen G, Holm R, Hagmar B, Johansson B (1998)
   Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis
   Int J Gynecol Pathol, 17 (2), 146-53
   PubMed 9553812
4. Smith-Sørensen B, Kaern J, Holm R, Dørum A, Tropé C, Børresen-Dale AL (1998)
   Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status
   Br J Cancer, 78 (3), 375-81
   PubMed 9703286
5. Sørlie T, Martel-Planche G, Hainaut P, Lewalter J, Holm R, Børresen-Dale AL, Montesano R (1998)
   Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines
   Br J Cancer, 77 (10), 1573-9
   PubMed 9635831

Publications 1997

1. Berner A, Franzén S, Holm R (1997)
   HPV 16 infection in a patient with two primary squamous cell carcinomas: of the uterine cervix and the anal mucosa
   APMIS, 105 (3), 207-12
   PubMed 9137516
2. Holm R, Flørenes VA, Erikstein B, Nesland JM (1997)
   Expression of stromelysin-3 in medullary carcinoma of the breast
   Anticancer Res, 17 (5B), 3725-7
   PubMed 9427769
3. Kareem BN, Karlsen F, Holm R, Hennig EM, Suo Z, Emilsen E, Hellesylt E, Nesland JM (1997)
   A novel grid polymerase chain reaction (G-PCR) approach at ultrastructural level to detect target DNA in cell cultures and tissues
   J Pathol, 183 (4), 486-93
   PubMed 9496267
4. Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD (1997)
   A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer
   Pathol Res Pract, 193 (7), 471-8
   PubMed 9342752
5. Lopes JM, Bruland OS, Bjerkehagen B, Silva MC, Holm R, Pettersen EO, Solheim OP, Sobrinho-Simões M, Nesland JM (1997)
   Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance
   Pathol Res Pract, 193 (1), 21-36
   PubMed 9112270
6. Skomedal H, Kristensen GB, Abeler VM, Børresen-Dale AL, Tropé C, Holm R (1997)
   TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas
   J Pathol, 181 (2), 158-65
   PubMed 9120719
7. Zhang Z, Suo Z, Sudbø J, Holm R, Boysen M, Reith A (1997)
   Diagnostic implications of p53 protein reactivity in nasal mucosa of nickel workers
   Anal Quant Cytol Histol, 19 (4), 345-50
   PubMed 9267568

Publications 1996

1. Chitemerere M, Andersen TI, Holm R, Karlsen F, Børresen AL, Nesland JM (1996)
   TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast
   Breast Cancer Res Treat, 41 (2), 103-9
   PubMed 8944328
2. Holm R, Tanum G (1996)
   Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study
   Virchows Arch, 428 (2), 85-9
   PubMed 8925129
3. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, Johansson B, Hagmar B (1996)
   Use of multiple PCR primer sets for optimal detection of human papillomavirus
   J Clin Microbiol, 34 (9), 2095-100
   PubMed 8862564
4. Kristensen GB, Holm R, Abeler VM, Tropé CG (1996)
   Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study
   Gynecol Oncol, 61 (3), 378-83
   PubMed 8641619
5. Kristensen GB, Holm R, Abeler VM, Tropé CG (1996)
   Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study
   Cancer, 78 (3), 433-40
   PubMed 8697388
6. Lie ES, Karlsen F, Holm R (1996)
   Presence of human papillomavirus in squamous cell laryngeal carcinomas. A study of thirty-nine cases using polymerase chain reaction and in situ hybridization
   Acta Otolaryngol, 116 (6), 900-5
   PubMed 8973730
7. Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O (1996)
   Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas
   Br J Cancer, 73 (8), 909-16
   PubMed 8611425
8. Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Flørenes VA (1996)
   Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions
   Am J Pathol, 149 (6), 1813-22
   PubMed 8952518
9. Tanum G, Holm R (1996)
   Anal carcinoma: a clinical approach to p53 and RB gene proteins
   Oncology, 53 (5), 369-73
   PubMed 8784470

Publications 1995

1. Flørenes VA, Holm R, Fodstad O (1995)
   Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome
   Melanoma Res, 5 (3), 183-7
   PubMed 7640520
2. Holm R (1995)
   Null cell adenomas and oncocytomas of the pituitary gland
   Pathol Res Pract, 191 (4), 348-52
   PubMed 7479351
3. Holm R, Høie J, Kaalhus O, Nesland JM (1995)
   Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland
   Virchows Arch, 427 (3), 289-94
   PubMed 7496599
4. Karlsen F, Kristensen G, Holm R, Chitemerere M, Berner A, Hagmar BM (1995)
   High incidence of human papillomavirus in 146 cervical carcinomas. A study using three different pairs of consensus primers, and detecting viral genomes with putative deletions
   Eur J Cancer, 31A (9), 1511-6
   PubMed 7577081
5. Lopes JM, Bjerkehagen B, Holm R, Bruland O, Sobrinho-Simões M, Nesland JM (1995)
   Proliferative activity of synovial sarcoma: an immunohistochemical evaluation of Ki-67 labeling indices of 52 primary and recurrent tumors
   Ultrastruct Pathol, 19 (2), 101-6
   PubMed 7792946
6. Skomedal H, Kristensen G, Helland A, Nesland JM, Kooi S, Børresen AL, Holm R (1995)
   TP53 gene mutations and protein accumulation in primary vaginal carcinomas
   Br J Cancer, 72 (1), 129-33
   PubMed 7599041
7. Skomedal H, Kristensen G, Holm R (1995)
   Expression of retinoblastoma tumor suppressor gene protein, epidermal growth factor receptor, and c-erbB-2 oncoprotein in primary vaginal carcinomas
   Gynecol Oncol, 59 (3), 379-83
   PubMed 8522259
8. Suo Z, Su W, Holm R, Nesland JM (1995)
   Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas
   Anticancer Res, 15 (6B), 2797-8
   PubMed 8669867

Publications 1994

1. Abeler VM, Holm R, Nesland JM, Kjørstad KE (1994)
   Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients
   Cancer, 73 (3), 672-7
   PubMed 8299089
2. Bjerkehagen B, Fosså SD, Raabe N, Holm R, Nesland JM (1994)
   Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV
   Eur Urol, 26 (4), 334-9
   PubMed 7713133
3. David L, Nesland JM, Holm R, Sobrinho-Simões M (1994)
   Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immunohistochemical study of 87 patients
   Cancer, 73 (3), 518-27
   PubMed 8299074
4. Flørenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O (1994)
   Expression of the neuroectodermal intermediate filament nestin in human melanomas
   Cancer Res, 54 (2), 354-6
   PubMed 8275467
5. Flørenes VA, Oyjord T, Holm R, Skrede M, Børresen AL, Nesland JM, Fodstad O (1994)
   TP53 allele loss, mutations and expression in malignant melanoma
   Br J Cancer, 69 (2), 253-9
   PubMed 7905277
6. Holm R, Nesland JM (1994)
   [Microwave oven in immunohistochemistry. An important tool for determination of antigens in formalin-fixed and paraffin-embedded tissue]
   Tidsskr Nor Laegeforen, 114 (20), 2392-4
   PubMed 7527943
7. Holm R, Nesland JM (1994)
   Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland
   J Pathol, 172 (3), 267-72
   PubMed 8195930
8. Holm R, Tanum G, Karlsen F, Nesland JM (1994)
   Prevalence and physical state of human papillomavirus DNA in anal carcinomas
   Mod Pathol, 7 (4), 449-53
   PubMed 8066073
9. Kristiansen E, Jenkins A, Holm R (1994)
   Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix
   J Clin Pathol, 47 (3), 253-6
   PubMed 7677803
10. Lopes JM, Bjerkehagen B, Holm R, Bruland O, Sobrinho-Simões M, Nesland JM (1994)
    Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation. A study of 49 primary tumours, recurrences and metastases
    Pathol Res Pract, 190 (2), 168-77
    PubMed 7520165
11. Makar AP, Holm R, Kristensen GB, Nesland JM, Tropé CG (1994)
    The expression of c-erbB-2 (HER-2/neu) oncogene in invasive ovarian malignancies
    Int J Gynecol Cancer, 4 (3), 194-199
    PubMed 11578406

Publications 1993

1. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Børresen AL (1993)
   Prognostic significance of TP53 alterations in breast carcinoma
   Br J Cancer, 68 (3), 540-8
   PubMed 8102535
2. Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL (1993)
   p53 abnormalities in different subtypes of human sarcomas
   Cancer Res, 53 (3), 468-71
   PubMed 8425179
3. Berner A, Holm R, Naess A, Hjortdal O (1993)
   p53 protein expression in squamocellular carcinomas of the lip
   Anticancer Res, 13 (6B), 2421-4
   PubMed 8135477
4. Gorczyca W, Holm R, Nesland JM (1993)
   Laminin production and fibronectin immunoreactivity in breast carcinomas
   Anticancer Res, 13 (4), 851-8
   PubMed 8394677
5. Heimdal K, Lothe RA, Lystad S, Holm R, Fosså SD, Børresen AL (1993)
   No germline TP53 mutations detected in familial and bilateral testicular cancer
   Genes Chromosomes Cancer, 6 (2), 92-7
   PubMed 7680893
6. Helland A, Holm R, Kristensen G, Kaern J, Karlsen F, Trope C, Nesland JM, Børresen AL (1993)
   Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas
   J Pathol, 171 (2), 105-14
   PubMed 8283348
7. Helseth A, Bautch VL, Haug E, Holm R, Nesland JM, Fodstad O (1993)
   [Transgenic mice as animal model of Cushing's syndrome]
   Tidsskr Nor Laegeforen, 113 (2), 206-10
   PubMed 8381565
8. HOLM R (1993)
   COEXPRESSION OF INSULIN AND SOMATOSTATIN IN SINGLE SECRETORY GRANULES OF A PANCREATIC ENDOCRINE TUMOR - COMMENTARY
   Pathol. Res. Pract., 189 (4), 464
9. Holm R, Abeler VM, Skomedal H, Nesland JM (1993)
   Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri
   Zentralbl Pathol, 139 (2), 153-6
   PubMed 8103676
10. Holm R, Helseth A, Nesland JM, Bautch VL (1993)
    ACTH-producing pituitary tumors in transgenic mice. An ultrastructural and immunoelectron microscopic study
    J Submicrosc Cytol Pathol, 25 (1), 29-36
    PubMed 8384929
11. Holm R, Skomedal H, Helland A, Kristensen G, Børresen AL, Nesland JM (1993)
    Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri
    J Pathol, 169 (1), 21-6
    PubMed 8433212
12. Peltomäki P, Lothe RA, Aaltonen LA, Pylkkänen L, Nyström-Lahti M, Seruca R, David L, Holm R, Ryberg D, Haugen A (1993)
    Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome
    Cancer Res, 53 (24), 5853-5
    PubMed 8261393
13. Suo Z, Holm R, Nesland JM (1993)
    Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours
    Histopathology, 23 (1), 45-54
    PubMed 7690007
14. Suo Z, Qvist H, Su W, Holm R, Giercksky KE, Nesland JM (1993)
    Undifferentiated carcinoma: an immunohistochemical and ultrastructural study
    Anticancer Res, 13 (3), 643-9
    PubMed 8317892

Publications 1992

1. Børresen AL, Helland A, Nesland J, Holm R, Trope C, Kaern J (1992)
   Papillomaviruses, p53, and cervical cancer
   Lancet, 339 (8805), 1350-1
   PubMed 1350005
2. David L, Seruca R, Nesland JM, Soares P, Sansonetty F, Holm R, Børresen AL, Sobrinho-Simões M (1992)
   c-erbB-2 expression in primary gastric carcinomas and their metastases
   Mod Pathol, 5 (4), 384-90
   PubMed 1353880
3. Holm R, Karlsen F, Nesland JM (1992)
   In situ hybridization with nonisotopic probes using different detection systems
   Mod Pathol, 5 (3), 315-9
   PubMed 1323105
4. Seruca R, David L, Holm R, Nesland JM, Fangan BM, Castedo S, Sobrinho-Simões M, Børresen AL (1992)
   P53 mutations in gastric carcinomas
   Br J Cancer, 65 (5), 708-10
   PubMed 1586599
5. Suo Z, Holm R, Nesland JM (1992)
   Squamous cell carcinomas, an immunohistochemical and ultrastructural study
   Anticancer Res, 12 (6B), 2025-31
   PubMed 1284199

Publications 1991

1. Nesland JM, Ottestad L, Børresen AL, Tvedt KE, Holm R, Heikkilä R, Tveit K (1991)
   The c-erbB-2 protein in primary and metastatic breast carcinomas
   Ultrastruct Pathol, 15 (3), 281-9
   PubMed 1678562
2. Nesland JM, Ottestad L, Heikilla R, Holm R, Tveit K, Børresen AL (1991)
   C-erbB-2 protein and neuroendocrine expression in breast carcinomas
   Anticancer Res, 11 (1), 161-7
   PubMed 1673329

Publications 1990

1. Sobrinho-Simoes M, Sambade C, Nesland JM, Holm R, Damjanov I (1990)
   Lectin histochemistry and ultrastructure of medullary carcinoma of the thyroid gland
   Arch Pathol Lab Med, 114 (4), 369-75
   PubMed 1690976

Publications 1989

1. Dasovi?-Knezevi? M, Børmer O, Holm R, Høie J, Sobrinho-Simões M, Nesland JM (1989)
   Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies
   Mod Pathol, 2 (6), 610-7
   PubMed 2587568
2. DASOVICKNEZEVIC M, BORMER O, HOLM R, HOIE J, SOBRINHOSIMOES M, NESLAND JM (1989)
   CARCINOEMBRYONIC ANTIGEN IN MEDULLARY-THYROID CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY APPLYING 6 NOVEL MONOCLONAL-ANTIBODIES
   Mod. Pathol., 2 (6), 610-617
3. Holm R, Farrants GW, Nesland JM, Sobrinho-Simões M, Jørgensen OG, Johannessen JV (1989)
   Ultrastructural and electron immunohistochemical features of medullary thyroid carcinoma
   Virchows Arch A Pathol Anat Histopathol, 414 (5), 375-84
   PubMed 2499093
4. Holm R, Nesland JM, Attramadal A, Halse J, Johannessen JV (1989)
   Null cell adenomas of the pituitary gland. An immunohistochemical study
   J Pathol, 158 (3), 213-7
   PubMed 2769482
5. Holm R, Nesland JM, Attramadal A, Reinli S, Johannessen JV (1989)
   Mixed growth hormone- and prolactin cell adenomas of the pituitary gland. An immunoelectron microscopic study
   J Submicrosc Cytol Pathol, 21 (2), 339-50
   PubMed 2752363
6. Kota?ska KM, Holm R, Ottestad L, Nesland JM (1989)
   An ultrastructural study of benign and malignant breast epithelial cells. A search for tonofilaments
   J Submicrosc Cytol Pathol, 21 (3), 469-74
   PubMed 2551480
7. KOTANSKA KM, HOLM R, OTTESTAD L, NESLAND JM (1989)
   AN ULTRASTRUCTURAL-STUDY OF BENIGN AND MALIGNANT BREAST EPITHELIAL-CELLS - A SEARCH FOR TONOFILAMENTS
   J. Submicrosc. Cytol. Pathol., 21 (3), 469-474

Publications 1988

1. Holm R, Nesland JM, Attramadal A, Johannessen JV (1988)
   Double-staining methods at the ultrastructural level applying colloidal gold conjugates
   Ultrastruct Pathol, 12 (3), 279-90
   PubMed 2456636
2. Holm R, Varndell IM, Power RF, Bishop AE, Madsen OD, Alpert S, Hanahan D, Polak JM (1988)
   Ultrastructure and electron immunocytochemistry of insulin-producing B-cell tumors from transgenic mice: comparison with counterpart human tumors
   Ultrastruct Pathol, 12 (5), 547-59
   PubMed 2848349
3. Nesland JM, Holm R, Johannessen JV, Gould VE (1988)
   Neuroendocrine differentiation in breast lesions
   Pathol Res Pract, 183 (2), 214-21
   PubMed 3290869
4. Nesland JM, Holm R, Ottestad L, Karlsen KO, Johannessen JV (1988)
   Neuroendocrine activity in metastatic breast carcinomas
   APMIS Suppl, 2, 204-14
   PubMed 2846016
5. NESLAND JM, HOLM R, OTTESTAD L, KARLSEN KO, JOHANNESSEN JV (1988)
   NEURO-ENDOCRINE ACTIVITY IN METASTATIC BREAST CARCINOMAS
   APMIS, 96 2, 204-214

Publications 1987

1. Holm R, Sobrinho-Simões M, Nesland JM, Sambade C, Johannessen JV (1987)
   Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity?
   Lab Invest, 57 (3), 258-68
   PubMed 3626517
2. Lunde S, Nesland JM, Holm R, Johannessen JV (1987)
   A urinary bladder tumor in a 65-year-old man
   Ultrastruct Pathol, 11 (1), 79-82
   PubMed 3824568
3. Lunde S, Nesland JM, Holm R, Johannessen JV (1987)
   Breast carcinomas with protein S-100 immunoreactivity. An immunocytochemical and ultrastructural study
   Pathol Res Pract, 182 (5), 627-31
   PubMed 2825146
4. Nesland JM, Holm R, Lunde S, Johannessen JV (1987)
   Diagnostic problems in breast pathology: the benefit of ultrastructural and immunocytochemical analysis
   Ultrastruct Pathol, 11 (2-3), 293-311
   PubMed 3035768
5. Nesland JM, Lunde S, Holm R, Johannessen JV (1987)
   Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells
   Histol Histopathol, 2 (1), 73-7
   PubMed 2980706
6. Power RF, Holm R, Bishop AE, Varndell IM, Alpert S, Hanahan D, Polak JM (1987)
   Transgenic mouse model: a new approach for the investigation of endocrine pancreatic B-cell growth
   Gut, 28 Suppl, 121-9
   PubMed 2826309

Publications 1986

1. Holm R, Sobrinho-Simões M, Nesland JM, Johannessen JV (1986)
   Concurrent production of calcitonin and thyroglobulin by the same neoplastic cells
   Ultrastruct Pathol, 10 (3), 241-8
   PubMed 3715999
2. Kjellevold K, Nesland JM, Holm R, Johannessen JV (1986)
   Multicystic peritoneal mesothelioma
   Pathol Res Pract, 181 (6), 767-73
   PubMed 2436202
3. Lunde S, Nesland JM, Holm R, Johannessen JV (1986)
   Primary malignant fibrous histiocytoma of the breast
   Histol Histopathol, 1 (1), 27-32
   PubMed 2856533
4. Nesland JM, Holm R, Johannessen JV (1986)
   A study of different markers for neuroendocrine differentiation in breast carcinomas
   Pathol Res Pract, 181 (5), 524-30
   PubMed 2431399
5. NESLAND JM, HOLM R, JOHANNESSEN JV (1986)
   ELECTRON-MICROSCOPY AND IMMUNOCYTOCHEMISTRY IN DIAGNOSTIC TUMOR PATHOLOGY
   J ELECTRON MICR TECH, 4 (2), 130-142
6. Nesland JM, Holm R, Johannessen JV (1986)
   Spindle cell tumor in the breast
   Ultrastruct Pathol, 10 (5), 415-9
   PubMed 2429416
7. Nesland JM, Holm R, Johannessen JV, Gould VE (1986)
   Neurone specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations
   J Pathol, 148 (1), 35-43
   PubMed 3003312
8. Nesland JM, Holm R, Sund BS, Johannessen JV (1986)
   A thyroid tumor in a 57-year-old man
   Ultrastruct Pathol, 10 (2), 197-202
   PubMed 3515708
9. NESLAND JM, HOLM R, SUND BS, JOHANNESSEN JV (1986)
   MEDULLARY CARCINOMA OF THE THYROID (AN UNUSUAL VARIANT) WITH METASTASIS TO THE URINARY-BLADDER - A THYROID-TUMOR IN A 57-YEAR-OLD MAN
   Ultrastruct. Pathol., 10 (2), 197-202
10. Sand O, Jonsson L, Nielsen M, Holm R, Gautvik KM (1986)
    Electrophysiological properties of calcitonin-secreting cells derived from human medullary thyroid carcinoma
    Acta Physiol Scand, 126 (2), 173-9
    PubMed 3705981
11. Sobrinho-Simões M, Stenwig AE, Nesland JM, Holm R, Johannessen JV (1986)
    A mucinous carcinoma of the thyroid
    Pathol Res Pract, 181 (4), 464-71
    PubMed 3020530

Publications 1985

1. Holm R, Gaarder PI, Helgeland L, Falkenhaug EI (1985)
   A human autoantibody to peroxisomes
   Clin Exp Immunol, 61 (2), 305-14
   PubMed 3899430
2. Holm R, Sobrinho-Simões M, Nesland JM, Gould VE, Johannessen JV (1985)
   Medullary carcinoma of the thyroid gland: an immunocytochemical study
   Ultrastruct Pathol, 8 (1), 25-41
   PubMed 3901454
3. Nesland JM, Holm R, Johannessen JV (1985)
   Ultrastructural and immunohistochemical features of lobular carcinoma of the breast
   J Pathol, 145 (1), 39-52
   PubMed 2578561
4. Nesland JM, Memoli VA, Holm R, Gould VE, Johannessen JV (1985)
   Breast carcinomas with neuroendocrine differentiation
   Ultrastruct Pathol, 8 (2-3), 225-40
   PubMed 4060259
5. Nesland JM, Sobrinho-Simões MA, Holm R, Johannessen JV (1985)
   Primitive neuroectodermal tumor (peripheral neuroblastoma)
   Ultrastruct Pathol, 9 (1-2), 59-64
   PubMed 3003993
6. Nesland JM, Sobrinho-Simões MA, Holm R, Johannessen JV (1985)
   Organoid tumor in the thyroid gland
   Ultrastruct Pathol, 9 (1-2), 65-70
   PubMed 4089997
7. Nesland JM, Sobrinho-Simões MA, Holm R, Sambade MC, Johannessen JV (1985)
   Hürthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry
   Ultrastruct Pathol, 8 (4), 269-90
   PubMed 4082297
8. NESLAND JM, SOBRINHOSIMOES MA, HOLM R, SAMBADE MC, JOHANNESSEN JV (1985)
   HURTHLE-CELL LESIONS OF THE THYROID - A COMBINED STUDY USING TRANSMISSION ELECTRON-MICROSCOPY, SCANNING ELECTRON-MICROSCOPY, AND IMMUNOCYTOCHEMISTRY
   Ultrastruct. Pathol., 8 (4), 269-290
9. Sobrinho-Simões MA, Nesland JM, Holm R, Johannessen JV (1985)
   Transmission electron microscopy and immunocytochemistry in the diagnosis of thyroid tumors
   Ultrastruct Pathol, 9 (3-4), 255-75
   PubMed 3911530
10. Sobrinho-Simões MA, Nesland JM, Holm R, Sambade MC, Johannessen JV (1985)
    Hürthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study
    Ultrastruct Pathol, 8 (2-3), 131-42
    PubMed 4060255
11. SOBRINHOSIMOES MA, NESLAND JM, HOLM R, SAMBADE MC, JOHANNESSEN JV (1985)
    HURTHLE CELL AND MITOCHONDRION-RICH PAPILLARY CARCINOMAS OF THE THYROID-GLAND - AN ULTRASTRUCTURAL AND IMMUNOCYTOCHEMICAL STUDY
    Ultrastruct. Pathol., 8 (2-3), 131-142

Publications 1983

1. Johannessen JV, Blom PG, Holm R, Normann T, Brennhovd IO (1983)
   Diagnosis of human tumors. Case 12: Medullary thyroid carcinoma forming follicles
   Ultrastruct Pathol, 5 (4), 347-52
   PubMed 6675221
2. JOHANNESSEN JV, BLOM PG, HOLM R, NORMANN T, BRENNHOVD IO (1983)
   MEDULLARY-THYROID CARCINOMA FORMING FOLLICLES
   Ultrastruct. Pathol., 5 (4), 347-352